Clinical data, including those from three identical pivotal phase III studies, have demonstrated that 2 mg prucalopride once daily is effective in increasing stool frequency, reducing constipation-related symptoms and improving quality of life [ 4– 6].
Supposedly this can not only reduce constipation, but also lead to weight loss, more energy, relief from allergies, and clearer skin.
These strains improved symptoms of infantile colic [9], feeding tolerance and gut function in pre-term infants [10], and reduced constipation or perceived pain intensity in children with functional abdominal pain [11].
Dietary fiber can aid in digestion, is helpful for weight management, and reduces constipation.
In this study we aim to determine the efficacy of methylnaltrexone per opioid subtype to reduce constipation.
Bixalomer (BXL) was developed to improve gastrointestinal symptoms and reduce constipation, relative to sevelamer hydrochloride, in hemodialysis patients.
Bedridden patients can dangle their feet on the bed and do arm and feet circling for at least 30 to 45 minutes daily to help promote the return of peristalsis (muscle contractions) in the gastrointestinal tract.[9] The early return of peristalsis can help reduce constipation.
